Gilead’s COVID med remdesivir is scarce and costly, AGs say, urging feds to sidestep its patents August 5, 2020 Auto Bot News 0 Gilead’s COVID med remdesivir is scarce and costly, AGs say, urging feds to sidestep its patents esagonowsky Wed, 08/05/2020 – 10:02
